This joint venture between Lung Foundation Australia and the Thoracic Society of Australia and New Zealand (TSANZ) will provide updates on the latest in real world diagnosis, management and research of Interstitial Lung Disease (ILD), Pulmonary Arterial Hypertension (PAH) and others. The program boasts keynote presentations from international speaker, Associate Professor David Lederer (USA), with the full agenda available below.


ARLDSC Program (202 KB)